- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, July 12, 2019
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
An article appearing in The New York Times cited a study published in The American Journal of Managed Care® (AJMC®). Researchers of the study, “Improving Provider Directory Accuracy: Can Machine-Readable Directories Help?,” examined the accuracy of provider directories and found widespread errors, leading them to conclude that machine-readable directories are not more accurate than conventional directories, despite their advantages. The study was also highlighted by Becker’s Hospital Review.
A Forbes article on biosimilars referred to an article from AJMC®’s sister site The Center for Biosimilars®. The article, “Biologics Are Not Monopolies to Be Regulated, AEI Economists Assert,” covered a blog post by 2 economists from the American Enterprise Institute in which they shot back at the idea that biosimilars are natural monopolies and should have their prices regulated by the government, which was proposed by critics a few months prior.
The Health Affairs blog referenced an AJMC® published study from May. The study, "Producing Comparable Cost and Quality Results From All-Payer Claims Databases," described a replicable process for standardizing disparate databases and methods to calculate cost and quality measures within and across states.
The AJMC® published study “Pharmacogenetic-Guided Psychiatric Intervention Associated With Increased Adherence and Cost Savings” was cited in an article from The Doctor Weighs In. According to the 2014 study, the data show the utility of pharmacogenetic testing in everyday psychiatric clinical practice, as it can lead to improved patient adherence and decreased healthcare costs.
The National Pharmaceutical Council’s Tuesday CER Daily Newsfeed included AJMC®’s article “Despite Growth, Uptake of Downside Risk in ACO Contracts Remains Low,” which covered a study that found in 2018, 33% of accountable care organizations assumed downside risk, up from 28% in 2012.
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Bridging Care Gaps With a Systemwide Value-Based Care Strategy
March 29th 2025Mapping care management needs by defining patient populations and then stratifying them according to risk and their needs can help to spur the transformation of a siloed health care system into an integrated system that is able to better provide holistic, value-based care despite the many transitions that continue among hospital, primary, specialty, and community care environments.
Read More
